Zer esan nahi du "Garbitu"?
Animaliak ez du mutazioa eramaten. Ez du gaixotasuna garatuko eta ez du pasako.
Cerebellar Hypoplasia (CHP) in White Swiss Shepherd Dogs is a genetic condition affecting coordination and balance. Early DNA testing for CHP helps breeders identify carriers and prevent passing this neurological disorder to puppies. Accurate CHP DNA tests ensure healthier litters and improve the overall well-being of White Swiss Shepherds. Understanding the genetic risks through testing supports responsible breeding practices. If you own a White Swiss Shepherd, consider CHP DNA testing to safeguard your dog's health. Reliable CHP testing services are available from specialized veterinary genetics labs. Protect your dog’s future with early detection and informed breeding decisions.
Cerebellar Hypoplasia (CHP) in White Swiss Shepherd Dogs is a genetic condition affecting the development of the cerebellum, leading to coordination and balance issues. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions. Early detection through testing helps manage the condition and reduce its prevalence in the breed. Responsible breeding practices rely on such genetic screening to maintain healthy bloodlines. Overall, the DNA test is a valuable tool for protecting the health of White Swiss Shepherd Dogs.
DNA proba hau gure paketetik hasita sartzen da Basic — eta paketeen parte ere bada Basic, Standard, Advanced, Complete.
Ikusi DNA Test paketeak →Cerebellar Hypoplasia (CHP) is a neurological condition affecting the development of the cerebellum, a part of the brain responsible for coordination and balance. In White Swiss Shepherd Dogs, this condition can lead to a range of motor skill challenges due to the underdevelopment of the cerebellum. Affected dogs may exhibit symptoms such as uncoordinated movement, difficulty walking, and tremors, which can significantly impact their quality of life.
The condition is believed to have a hereditary component, and it is caused by genetic mutations that interfere with normal brain development. Identifying these mutations through DNA testing can help breeders make informed decisions and reduce the prevalence of CHP in future generations. Understanding the genetic basis of this condition is crucial for managing and breeding practices, as it allows for the identification of carriers and affected individuals.
Dogs with Cerebellar Hypoplasia may display a variety of clinical signs that can vary in severity. Common symptoms include difficulty with balance, an unsteady gait, and abnormal head movements. Some dogs may also exhibit signs of anxiety or stress due to their inability to coordinate movements effectively. These symptoms often become apparent at a young age, and while the condition is not progressive, it requires careful management to ensure the well-being of the affected dog.
Diagnosis of CHP typically involves a combination of clinical evaluation and genetic testing. Veterinarians may assess the dog’s physical condition and observe its motor skills to identify potential neurological issues. Genetic testing can confirm the presence of mutations associated with the condition, providing a clearer understanding of the dog's health status and potential risks for breeding.
While there is currently no cure for Cerebellar Hypoplasia, affected dogs can lead fulfilling lives with appropriate management strategies. Owners should focus on creating a safe environment that minimizes the risk of injury due to mobility challenges. Regular veterinary check-ups, tailored exercise programs, and supportive care can help enhance the quality of life for dogs with CHP. Additionally, engaging in positive reinforcement training can assist in building confidence and improving coordination.
Cerebellar Hypoplasia in White Swiss Shepherd Dogs is a condition that requires attention from breeders, veterinarians, and dog owners alike. By understanding the genetic underpinnings and clinical implications of CHP, stakeholders can work towards responsible breeding practices and improved care for affected dogs. Awareness and education are key in ensuring that these dogs receive the support they need to thrive.
Animaliak ez du mutazioa eramaten. Ez du gaixotasuna garatuko eta ez du pasako.
Ez. Animalia, oro har, osasuntsua da, baina mutazioa transmititu diezaioke kumeak.
Bi kopia mutatuta daramatza. Seinale klinikoak espero dira gaixotasuna. Ez da hazi behar.
Gaixotasun batzuk sexuarekin lotuta daude, beraz, haien adierazpena aldatu egiten da animalien sexua.
This DNA test detects the mutation associated with Cerebellar Hypoplasia In White Swiss Shepherd Dog (CHP-WSS) in order to identify clear, carrier, or at-risk animals.
DNA probak hazleei estalketa seguruagoak planifikatzen eta mutazioa ondorengoei transmititzeko arriskua murrizten laguntzen die.
Proba honetarako jakinarazitako herentzia modua Autosomiko Errezesiboa da.
This test analyses the mutation RELN c.2839del.
Ez derrigorrez. Interpretazioa herentzia-ereduaren eta ondoriozko genotipoaren araberakoa da.
Littlejohn Mathew D, Sneddon Nick, Dittmer Keren, Keehan Mike, Stephen Melissa, Drögemüller Michaela, Garrick Dorian. A frameshift-deletion mutation in Reelin causes cerebellar hypoplasia in White Swiss Shepherd dogs. Anim Genet. 2023 Oct;54(5):632-636. doi: 10.1111/age.13336. Epub 2023 Jun 19.
Zure pribatutasuna, zure aukera
Ezinbesteko cookieak erabiltzen ditugu webgunea exekutatzeko. Aukerako cookieak (adibidez, kapsulatutako eduki-hornitzaileak) lehenespenez desgaituta daude eta onartzen baduzu soilik gaituta daude. Zure aukera edonoiz alda dezakezu "Cookieak" botoia erabiliz.
Beharrezkoa da oinarrizko funtzioetarako eta segurtasunerako. Beti gaituta.
Hobespenak gordetzea edo publizitaterik gabeko kapsulatzeak bezalako eginbideak hobetzen ditu.
Gunearen erabilera ulertzen laguntzen digu. Lehenespenez desgaituta dago.
Publizitatea/jarraipena guneetan zehar (bideo/mapa batzuk kapsulatzen dira). Lehenespenez desgaituta dago.